Aspirin does not reduce heart attack, stroke risk: Study
Three studies were conducted and the report was published in New England Journal of Medicine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 130
Browsing Category
Latest Updates
Lupin’s Nagpur facility inspection concludes with no observation
This inspection was a product specific pre-approval inspection
Kusum group of companies launches 90 crore Indore manufacturing plant
Constructed on a land area of over 4.8 acres, the state-of-the-art Greenfield manufacturing plant is located at special economic…
Sun Pharma, SPARC announce FDA approval of Xelpros
Xelpros (latanoprost ophthalmic emulsion) 0.005 per cent for topical ophthalmic use is the first and only benzalkonium…
Alkem Laboratories donates ₹1 crore towards CM relief fund in Kerala
Additional INR 0.41 crore will be donated towards relief and humanitarian aid for the flood-affected areas
Lupin receives FDA approval for generic Atovaquone Oral Solution USP
Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, 750…
DRL launches muscle disease drug in US
The company's product is the generic version of Bloxiverz Injection
Global Interstitial Cystitis, Bladder Pain Society concludes 3rd annual scientific conference
The objective was to strengthen the existing working principles and take the plunge to innovative steps in the management of…
Over 9500 visitors attend India Lab expo, analytica Anacon India and Pharma Pro&Pack expo 2018
There were around 261 exhibitors from India and overseas at the trade fair trio
Health Ministry prohibits manufacture or distribution for human use of 328 FDCs
The Drugs Technical Advisory Board recommended, amongst other things, that these FDCs may involve risk to human beings